Israel · Delayed Price · Currency is ILS · Price in ILA Evogene Company Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa.
It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine.
It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products.
It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD).
The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Contact Details
Address: 13 Gad Feinstein Street Rehovot, 7638517 Israel | |
| Phone | 972 8 931 1900 |
| Website | evogene.com |
Stock Details
| Ticker Symbol | EVGN |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011050551 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dan Jacob Gelvan Ph.D. | Chief Executive Officer of Ag Plenus Ltd. |
| Yoash Zohar | Chief Executive Officer of Casterra Ag Ltd. |
| Ofer Haviv CPA | Chief Executive Officer, President and Director |
| Polina Ravzin | Chief Financial Officer |
| Dr. Ilia Zhidkov | Chief Technology Officer |
| Liat Foigel Wejgman | Vice President of Human Resources |
| Dr. Gabi Tarcic Ph.D. | Chief Development Officer |